Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) regulates energy homeostasis via activation of the GLP-1 receptors (GLP-1Rs) in the central nervous system. However, the mechanism by which the central GLP-1 signal controls blood glucose levels, especially in different nutrient states, remains unclear. Here, we defined a population of glucose-sensing GLP-1R neurons in the dorsomedial hypothalamic nucleus (DMH), by which endogenous GLP-1 decreases glucose levels via the cross-talk between the hypothalamus and pancreas. Specifically, we illustrated the sufficiency and necessity of DMH GLP-1R in glucose regulation. The activation of the DMH GLP-1R neurons is mediated by a cAMP-PKA–dependent inhibition of a delayed rectifier potassium current. We also dissected a descending control of DMH GLP-1R –dorsal motor nucleus of the vagus nerve (DMV)–pancreas activity that can regulate glucose levels by increasing insulin release. Thus, our results illustrate how central GLP-1 action in the DMH can induce a nutrient state–dependent reduction in blood glucose level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1. Exogenous GLP-1 decreases blood glucose level in the DMH. (A) Experimental paradigm for ICV injection GLP-1R agonist Exn4 experiment in WT mice. (B) ICV Exn4 caused decrease in fasting blood glucose. *P < 0.05 and ***P < 0.001 (t test). (C) To investigate DMH GLP-1R neuron response to Exn4 injection, we injected adeno-associated virus (AAV)–DIO–mCherry in the DMH of GLP-1R-Cre mice and stained with c-Fos antibody. The representative images showed that ICV Exn4 did increase c-Fos expression in GLP-1R neurons within the DMH. (D) Quantification of c-Fos–positive cell ration (relative to total GLP-1R neurons). ***P < 0.001 (t test). (E) Experimental paradigm for Exn4 injection in DMH of WT mice. (F) Fasting blood glucose decreased after Exn4 injection, an effect that was antagonized by the cAMP-PKA blocker, cAMP-Rp. *P < 0.05, **P < 0.01, and ***P < 0.001 [analysis of variance (ANOVA)], vehicle versus Exn4; #P < 0.05 (ANOVA), Exn4 versus Exn4 + cAMP-Rp (ANOVA). Numbers of animals are indicated in each panel.](https://figures.cochat.ai/paper-figures/e4e7ef7ae0eb4252a0ac638401001932/glucose-sensing-glucagon-like-peptide-1-receptor-neurons-in-the-dorsomedial-figure-1.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The DMH plays a pivotal role in long-term metabolic regulation, including energy expenditure, thermogenesis, and circadian rhythm (27–29).”
From GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans (2024) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · cited 2×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundMechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170 · cited 1×
“One important advantage of GLP-1–based therapies for diabetes is that GLP-1–induced insulin release is dependent on circulating glucose levels, making GLP-1–based therapies less likely than other insulin secretagogues to cause hypoglycemia (3, 4).”
BackgroundGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Self-citationChannelrhodopsin-2-assisted circuit mapping of long-range callosal projections
Petreanu, L., Huber, D., Sobczyk, A., & Svoboda, K. (2007) · Nature Neuroscience · doi:10.1038/nn1891 · Cited by 930 · cited 3×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundMethodPyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876
Larsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663
An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger
Krashes, M. J., Shah, B. P., Madara, J. C., Olson, D. P., Strochlic, D. E., Garfield, A. S., Vong, L., Pei, H., Watabe-Uchida, M., Uchida, N., et al. (2014) · Nature · doi:10.1038/nature12956 · Cited by 603
Exon duplication and divergence in the human preproglucagon gene
Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C. (1983) · Nature · doi:10.1038/304368a0 · Cited by 593
Cork, S. C., Richards, J. E., Holt, M. K., Gribble, F. M., Reimann, F., & Trapp, S. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.008 · Cited by 478
Discovery, characterization, and clinical development of the glucagon-like peptides
Drucker, D. J., Habener, J. F., & Holst, J. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci97233 · Cited by 418 · cited 1×
“One important advantage of GLP-1–based therapies for diabetes is that GLP-1–induced insulin release is dependent on circulating glucose levels, making GLP-1–based therapies less likely than other insulin secretagogues to cause hypoglycemia (3, 4).”
Background
Cited by
GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans
Kim, K. S., Park, J. S., Hwang, E., Park, M. J., Shin, H. Y., Lee, Y. H., Kim, K. M., Gautron, L., Godschall, E., Portillo, B., et al. (2024) · Science · doi:10.1126/science.adj2537 · Cited by 148
Singh, I., Wang, L., Xia, B., Liu, J., Tahiri, A., El Ouaamari, A., Wheeler, M. B., & Pang, Z. P. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00914-3 · Cited by 98
“The morphological analysis of the axonal terminals revealed dense GLP-1 neuronal terminals in the hypothalamus, especially in the PVN, DMH, ARC, and the medial vestibular parvicellular subfields nucleus (MvePC) (Fig.”
BackgroundResultSelf-citationBlood‐Glucose‐Powered Metabolic Fuel Cell for Self‐Sufficient Bioelectronics
Maity, D., Ray, P. G., Buchmann, P., Mansouri, M., & Fussenegger, M. (2023) · Advanced Materials · doi:10.1002/adma.202300890 · Cited by 70
GLP-1 programs the neurovascular landscape
Chen, B., Yu, X., HORVATH-DIANO, C., Ortuño, M. J., Tschöp, M. H., Jastreboff, A. M., & Schneeberger, M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.003 · Cited by 62
Liu, L., Huang, Z., Zhang, J., Wang, M., Yue, T., Wang, W., Wu, Y., Zhang, Z., Xiong, W., Wang, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52815-3 · Cited by 58
Self-citation
Metadata
- Authors
- Huang, Z., Liu, L., Zhang, J., Conde, K., Phansalkar, J., Li, Z., Yao, L., Xu, Z., Wang, W., Zhou, J., Bi, G., Wu, F., Seeley, R. J., Scott, M. M., Zhan, C., Pang, Z. P., & Liu, J.
- Affiliations
- University of Science and Technology of China (CN)
- Rutgers, The State University of New Jersey (US)
- CAS Key Laboratory of Brain Function and Diseases, Life Science School, University of Science and Technology of China, Anhui, China.
- Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, China.
- University of Michigan (US)
- University of Virginia (US)
- Corresponding author
- Huang, Zhaohuan
- Liu, Ling
- Zhang, Jian
- Liu, Ji
- ORCID
- Venue
- Science Advances
- Published
- 2022-06-10
- Volume
- 8
- Issue
- 23
- Pages
- eabn5345-eabn5345
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC9177072
- OpenAlex
- W4282930998
- Cited by
- 78
- References
- 57
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 15 · 2023: 14 · 2022: 4
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH116694)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020572)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucagon-like peptide-1, GLP-1 receptor, dorsomedial hypothalamus, glucose detection, blood glucose regulation, energy homeostasis, dorsal motor nucleus of the vagus, insulin secretion, cAMP/PKA signaling, delayed rectifier potassium current
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Blood Glucose, Glucose, Hypothalamus, Neurons, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism. https://app.cochat.ai/papers/10.1126/sciadv.abn5345
- The paper
- Huang, Z., Liu, L., Zhang, J., Conde, K., Phansalkar, J., Li, Z., Yao, L., Xu, Z., Wang, W., Zhou, J., Bi, G., Wu, F., Seeley, R. J., Scott, M. M., Zhan, C., Pang, Z. P., & Liu, J. (2022). Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism. Science Advances. https://doi.org/10.1126/sciadv.abn5345
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.